메뉴 건너뛰기




Volumn 6, Issue 4, 2006, Pages 345-350

Targeting B cells in SLE: The experience with rituximab treatment (Anti-CD20)

Author keywords

B cells; CD20; Chimeric monoclonal antibody; Rituximab; SLE

Indexed keywords

ACICLOVIR; AUTOANTIBODY; AZATHIOPRINE; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; PREDNISONE; RITUXIMAB; STEROID;

EID: 33845654722     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153006779025757     Document Type: Article
Times cited : (19)

References (96)
  • 22
  • 47
    • 0036566507 scopus 로고    scopus 로고
    • Polyak, M. J. and Deans, J. P. (2002) Blood, 99(9), 3256-3262.
    • (2002) Blood , vol.99 , Issue.9 , pp. 3256-3262
    • Polyak, M.J.1    Deans, J.P.2
  • 63
    • 33845600540 scopus 로고    scopus 로고
    • Rituximab package insert
    • Rituximab package insert (2006).
    • (2006)
  • 80
    • 29844451692 scopus 로고    scopus 로고
    • author reply 122-123
    • Okamoto, H. (2006) Rheumatology (Oxford), 45(1), 121-122; author reply 122-123.
    • (2006) Rheumatology (Oxford) , vol.45 , Issue.1 , pp. 121-122
    • Okamoto, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.